CD19 chimeric antigen receptor T cell therapy for haematological malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD19 chimeric antigen receptor T cell therapy for haematological malignancies

Published:2015-03-05 Issue:4 Volume:169 Page:463-478
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ghorashian Sara¹,Pule Martin²³⁴,Amrolia Persis¹⁵

Affiliation:

1. Molecular and Cellular Immunology Unit; Institute of Child Health; University College London; London UK

2. Department of Haematology; Cancer Institute; University College London; London UK

3. NIHR University College London Hospitals Biomedical Research Centre; London UK

4. Department of Haematology; University College Hospitals NHS Trust; London UK

5. Department of Bone Marrow Transplantation; Great Ormond Street Hospital for Children National Health Service Trust; London UK

Funder

National Institute for Health Research

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13340/fullpdf

Reference80 articles.

1. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity;Adusumilli;Science Translational Medicine,2014

2. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells;Antony;Journal of Immunology,2005

3. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates;Berger;Journal of Clinical Investigation,2008

4. Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity;Bollard;Blood,2002

5. Small-molecule displacement of a cryptic degron causes conditional protein degradation;Bonger;Nature Chemical Biology,2011

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics;Biology;2023-11-11

2. Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining;Cytometry Part A;2023-09-27

3. Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR;Molecular Therapy;2023-07

4. Chimeric antigen receptor T ( CAR‐T ) cells: Novel cell therapy for hematological malignancies;Cancer Medicine;2022-12-30

5. Gene knockout in cellular immunotherapy: Application and limitations;Cancer Letters;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3